Changes of erythrocytic immune function and T lymphocyte subsets of peripheral blood in patients with lung cancer and then clinical significance
Duan Ming
Abstract
Duan Ming
Abstract
Objective:To study the changes of erythrocytic immune function and T lymphocyte subsets in lung cancer patients.Methods:Erythrocyte immune functions and T lymphocyte subsets were detected in 55 cases of lung cancer;15 cases of lung benign neoplasm and 20 healthy persons were chosen as control.Results:(1)RRC-C3bRR,CD3 +,CD4 +,CD8 +,CD4 +/CD8 + ratio of lung cancer patients were significantly lower than those of healthy group( P 0 05);however RBC-1CR of lung cancer patients were significantly higher than those of lung benign neoplasm and healthy group( P 0 05) in turn.(2)RBC-C3bRR,CD3 +,CD4 +,CD4 +/CD8 + ratio of Ⅲa,Ⅲb staged lung cancer patients were significantly lower than those of Ⅰ,Ⅱ stages and healthy group ( P 0 05);RBC-1CR of Ⅲa,Ⅲb stage in lung cancer patients was significantly higher than those of healthy group( P 0 01),CD3 +,CD4 +,CD8 + of stage Ⅰ,Ⅱ patients were significantly lower than those of healthy group( P 0 01),and RBC-1CR of stage Ⅰ,Ⅱ patlents was significantly higher( P 0 01).Conclusion:Detection of erythrocyte immune functions and T lymphocyte subsets may be useful in the diagnosis,treatment and prognos is of lung cancer.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective:To study the changes of erythrocytic immune function and T lymphocyte subsets in lung cancer patients.Methods:Erythrocyte immune functions and T lymphocyte subsets were detected in 55 cases of lung cancer;15 cases of lung benign neoplasm and 20 healthy persons were chosen as control.Results:(1)RRC-C3bRR,CD3 +,CD4 +,CD8 +,CD4 +/CD8 + ratio of lung cancer patients were significantly lower than those of healthy group( P 0 05);however RBC-1CR of lung cancer patients were significantly higher than those of lung benign neoplasm and healthy group( P 0 05) in turn.(2)RBC-C3bRR,CD3 +,CD4 +,CD4 +/CD8 + ratio of Ⅲa,Ⅲb staged lung cancer patients were significantly lower than those of Ⅰ,Ⅱ stages and healthy group ( P 0 05);RBC-1CR of Ⅲa,Ⅲb stage in lung cancer patients was significantly higher than those of healthy group( P 0 01),CD3 +,CD4 +,CD8 + of stage Ⅰ,Ⅱ patients were significantly lower than those of healthy group( P 0 01),and RBC-1CR of stage Ⅰ,Ⅱ patlents was significantly higher( P 0 01).Conclusion:Detection of erythrocyte immune functions and T lymphocyte subsets may be useful in the diagnosis,treatment and prognos is of lung cancer.
Key concepts: Lung cancer, Immune system, CD8, Medicine, Lung, Cancer, CD3, Stage (stratigraphy)